Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Hsa_circ_0005075 predicts a poor prognosis and acts as an oncogene in colorectal cancer via activating Wnt/╬▓-catenin pathway.

Jin YD, Ren YR, Gao YX, Zhang L, Ding Z.

Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3311-3319. doi: 10.26355/eurrev_201904_17693.

2.

Screening, verification, and analysis of biomarkers for drug-induced cardiac toxicity in vitro based on RTCA coupled with PCR Array technology.

Zhang L, Xu MX, Yin QS, Zhu CY, Cheng XL, Ren YR, Zhuang PW, Zhang YJ.

Toxicol Lett. 2017 Feb 15;268:17-25. doi: 10.1016/j.toxlet.2017.01.007. Epub 2017 Jan 15.

PMID:
28099878
3.

Ubiquitination-Related MdBT Scaffold Proteins Target a bHLH Transcription Factor for Iron Homeostasis.

Zhao Q, Ren YR, Wang QJ, Wang XF, You CX, Hao YJ.

Plant Physiol. 2016 Nov;172(3):1973-1988. Epub 2016 Sep 22.

4.

Efficacy and tolerance of pegaspargase, gemcitabine and oxaliplatin with sandwiched radiotherapy in the treatment of newly-diagnosed extranodal nature killer (NK)/T cell lymphoma.

Jing XM, Zhang ZH, Wu P, Zhang SC, Ren YR, Xiong ZJ, Wei W, Luo L, Li L.

Leuk Res. 2016 Aug;47:26-31. doi: 10.1016/j.leukres.2016.05.004. Epub 2016 May 12.

PMID:
27239738
5.

Overexpression of MdbHLH104 gene enhances the tolerance to iron deficiency in apple.

Zhao Q, Ren YR, Wang QJ, Yao YX, You CX, Hao YJ.

Plant Biotechnol J. 2016 Jul;14(7):1633-45. doi: 10.1111/pbi.12526. Epub 2016 Jan 23.

6.

Rituximab treatment strategy for patients with diffuse large B-cell lymphoma after first-line therapy: a systematic review and meta-analysis.

Ren YR, Jin YD, Zhang ZH, Li L, Wu P.

Chin Med J (Engl). 2015 Feb 5;128(3):378-83. doi: 10.4103/0366-6999.150111. Review.

7.

Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes.

Ghosh S, Sur S, Yerram SR, Rago C, Bhunia AK, Hossain MZ, Paun BC, Ren YR, Iacobuzio-Donahue CA, Azad NA, Kern SE.

Am J Pathol. 2014 Jan;184(1):260-70. doi: 10.1016/j.ajpath.2013.09.023. Epub 2013 Nov 6.

8.

FAM190A deficiency creates a cell division defect.

Patel K, Scrimieri F, Ghosh S, Zhong J, Kim MS, Ren YR, Morgan RA, Iacobuzio-Donahue CA, Pandey A, Kern SE.

Am J Pathol. 2013 Jul;183(1):296-303. doi: 10.1016/j.ajpath.2013.03.020. Epub 2013 May 10.

9.

[In vitro antitumor activities and mechanisms of galactosylated artemisinin].

Ren YR.

Zhong Yao Cai. 2012 Jul;35(7):1116-20. Chinese.

PMID:
23252279
10.

[Nitrate storage and transport within a typical karst aquifer system in the paralleled ridge-valley of east Sichuan].

Yang PH, Yuan DX, Ren YR, Xie SY, He QF, Hu XF.

Huan Jing Ke Xue. 2012 Sep;33(9):3124-31. Chinese.

PMID:
23243869
11.

Unbiased discovery of interactions at a control locus driving expression of the cancer-specific therapeutic and diagnostic target, mesothelin.

Ren YR, Chaerkady R, Hu S, Wan J, Qian J, Zhu H, Pandey A, Kern SE.

J Proteome Res. 2012 Nov 2;11(11):5301-10. doi: 10.1021/pr300797v. Epub 2012 Oct 12.

12.

Enhanced high-rate performance of double-walled TiO2-B nanotubes as anodes in lithium-ion batteries.

Qu J, Wu QD, Ren YR, Su Z, Lai C, Ding JN.

Chem Asian J. 2012 Nov;7(11):2516-8. doi: 10.1002/asia.201200551. Epub 2012 Sep 4.

PMID:
22945850
13.

Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease.

Yasuda T, Hayakawa H, Nihira T, Ren YR, Nakata Y, Nagai M, Hattori N, Miyake K, Takada M, Shimada T, Mizuno Y, Mochizuki H.

J Neuropathol Exp Neurol. 2011 Aug;70(8):686-97. doi: 10.1097/NEN.0b013e3182269ecd.

PMID:
21760537
14.

Left atrial diameter, flow-mediated dilation of brachial artery and target organ damage in Chinese patients with hypertension.

Xu JZ, Wu SY, Yan YQ, Xie YS, Ren YR, Yin ZF, Shi CZ, Wang CQ.

J Hum Hypertens. 2012 Jan;26(1):41-7. doi: 10.1038/jhh.2010.129. Epub 2011 Feb 3.

PMID:
21289644
15.

Structural analysis of the cancer-specific promoter in mesothelin and in other genes overexpressed in cancers.

Ren YR, Patel K, Paun BC, Kern SE.

J Biol Chem. 2011 Apr 8;286(14):11960-9. doi: 10.1074/jbc.M110.193458. Epub 2011 Feb 2.

16.

Impaired in vivo dopamine release in parkin knockout mice.

Oyama G, Yoshimi K, Natori S, Chikaoka Y, Ren YR, Funayama M, Shimo Y, Takahashi R, Nakazato T, Kitazawa S, Hattori N.

Brain Res. 2010 Sep 17;1352:214-22. doi: 10.1016/j.brainres.2010.06.065. Epub 2010 Jul 8.

PMID:
20620130
17.

Improved DNA electrophoresis in conditions favoring polyborates and lewis acid complexation.

Singhal H, Ren YR, Kern SE.

PLoS One. 2010 Jun 25;5(6):e11318. doi: 10.1371/journal.pone.0011318.

18.

Cholesterol trafficking is required for mTOR activation in endothelial cells.

Xu J, Dang Y, Ren YR, Liu JO.

Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4764-9. doi: 10.1073/pnas.0910872107. Epub 2010 Feb 22.

19.

Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.

Zhang Y, Byun Y, Ren YR, Liu JO, Laterra J, Pomper MG.

Cancer Res. 2009 Jul 15;69(14):5867-75. doi: 10.1158/0008-5472.CAN-08-4866. Epub 2009 Jun 30.

20.

Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.

Yasuda T, Nihira T, Ren YR, Cao XQ, Wada K, Setsuie R, Kabuta T, Wada K, Hattori N, Mizuno Y, Mochizuki H.

J Neurochem. 2009 Feb;108(4):932-44. doi: 10.1111/j.1471-4159.2008.05827.x. Epub 2009 Jan 7.

21.

Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes.

Ren YR, Pan F, Parvez S, Fleig A, Chong CR, Xu J, Dang Y, Zhang J, Jiang H, Penner R, Liu JO.

PLoS One. 2008;3(12):e4009. doi: 10.1371/journal.pone.0004009. Epub 2008 Dec 23.

22.

Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth.

Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, Rey S, Hammers H, Chang D, Pili R, Dang CV, Liu JO, Semenza GL.

Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19579-86. doi: 10.1073/pnas.0809763105. Epub 2008 Nov 19.

23.

Alteration in the differentiation-related molecular expression in the subventricular zone in a mouse model of Parkinson's disease.

Oizumi H, Hayashita-Kinoh H, Hayakawa H, Arai H, Furuya T, Ren YR, Yasuda T, Seki T, Mizuno Y, Mochizuki H.

Neurosci Res. 2008 Jan;60(1):15-21. Epub 2007 Sep 18.

PMID:
17963913
24.

Reading dynamic kinase activity in living cells for high-throughput screening.

Allen MD, DiPilato LM, Rahdar M, Ren YR, Chong C, Liu JO, Zhang J.

ACS Chem Biol. 2006 Jul 21;1(6):371-6.

PMID:
17163774
25.

Neuronal specificity of alpha-synuclein toxicity and effect of Parkin co-expression in primates.

Yasuda T, Miyachi S, Kitagawa R, Wada K, Nihira T, Ren YR, Hirai Y, Ageyama N, Terao K, Shimada T, Takada M, Mizuno Y, Mochizuki H.

Neuroscience. 2007 Jan 19;144(2):743-53. Epub 2006 Nov 13.

PMID:
17101231
26.

Recombinant human granulocyte colony-stimulating factor protects against MPTP-induced dopaminergic cell death in mice by altering Bcl-2/Bax expression levels.

Cao XQ, Arai H, Ren YR, Oizumi H, Zhang N, Seike S, Furuya T, Yasuda T, Mizuno Y, Mochizuki H.

J Neurochem. 2006 Nov;99(3):861-7.

27.

Statistical parametric mapping of immunopositive cell density.

Wada M, Yoshimi K, Higo N, Ren YR, Mochizuki H, Mizuno Y, Kitazawa S.

Neurosci Res. 2006 Sep;56(1):96-102. Epub 2006 Jul 17.

PMID:
16846658
28.

Genetic vitamin E deficiency does not affect MPTP susceptibility in the mouse brain.

Ren YR, Nishida Y, Yoshimi K, Yasuda T, Jishage K, Uchihara T, Yokota T, Mizuno Y, Mochizuki H.

J Neurochem. 2006 Sep;98(6):1810-6. Epub 2006 Jun 19.

29.

Possibility for neurogenesis in substantia nigra of parkinsonian brain.

Yoshimi K, Ren YR, Seki T, Yamada M, Ooizumi H, Onodera M, Saito Y, Murayama S, Okano H, Mizuno Y, Mochizuki H.

Ann Neurol. 2005 Jul;58(1):31-40.

PMID:
15912513
30.

[The use of heart pacemaker in surgical treatment of patients with oral cancer and sick sinus syndrome]

Sun J, Ren YR, Qiu WL, Li GC, Zhang ZY.

Shanghai Kou Qiang Yi Xue. 1995 Sep;4(3):162. Chinese. No abstract available.

PMID:
15160083

Supplemental Content

Support Center